通过过敏免疫疗法长期医疗保健资源和成本节省:REACT研究结果
Benedikt Fritzsching1, Celeste Porsbjerg2, Marco Contoli3
1Paediatric Pulmonology and Allergy, Children's Doctor Service, Heidelberg, Germany.
The journal of allergy and clinical immunology. Global
|January 16, 2024
概括
过敏免疫疗法 (AIT) 减少了长期医疗保健的使用和成本. 虽然初始成本较高,但观察到持续的好处,在家用舌下免疫疗法 (SLIT) 片可能降低门诊护理费用.
科学领域:
- 免疫学和过敏学
- 卫生经济学 卫生经济学
- 现实世界的证据研究研究.
背景情况:
- 过敏免疫疗法 (AIT) 包括皮下免疫疗法 (SCIT) 和舌下免疫疗法 (SLIT) 片.
- 对于AIT的持续作用,建议进行3年的治疗时间.
研究的目的:
- 评估过敏性鼻炎患者的长期医疗保健资源使用 (HRU) 和与AIT (SCIT和SLIT) 相关的成本.
- 为了比较AIT和非AIT组之间的HRU和成本,以及SCIT和SLIT子组之间的HRU和成本.
主要方法:
- 使用德国索赔数据 (2007-2017年) 的回顾性队列研究 (REACT).
- 倾向性得分匹配被用来比较AIT接收者与对照.
- 长达9年的随访评估了住院,门诊护理和处方数据.
主要成果:
- 与对照组相比,AIT显著降低了长期住院的发生率.
- 一般来说,SLIT平板显示出较低的门诊护理访问和住院比SCIT.
- 在1-3年期间,AIT总成本较高,但在4-9年期间较低,主要是因为处方和门诊护理成本.
结论:
- 最初更高的HRU和AIT成本被长期节省所抵消.
- 在家中服用SLIT片剂可能会进一步降低门诊护理费用.
相关概念视频
Allergic Reactions
27.4K
Overview
27.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Cross-reactivity
31.1K
Overview
31.1K
Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445
Antibody Structure
60.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.2K
Allergic Drug Reactions
845
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
845


